CD274 and glioblastoma: The number of glioblastoma stem cell-derived PD-L1-EVs increased after treatment with temozolomide, increasing intracellular PD-L1 levels after ingestion by tumor cells and subsequently inducing AMPK/ULK1 pathway-mediated protective autophagy, resulting in tolerance to temozolomide by clearing damaged organelles within cells95.